BRCA and Familial Breast Risk

• Who is offered testing?+−

  Tap for details

  New breast cancer ≤65, triple-negative disease, male breast cancer, bilateral disease, strong family history, or a known family mutation are common triggers in current frameworks.

• Surgical decisions+−

  Tap for details · key note inside

  Mastectomy versus breast conservation, contralateral risk-reducing choices, and ovarian-risk conversations are individualized — not a single mandatory operation.

• Surveillance+−

  Tap for details

  High-risk pathways often combine yearly mammography with breast MRI. Start age depends on counseling and the earliest family diagnosis.

• Important+−

  Tap for details · key note inside

  This page is for education. It is not medical advice and does not replace a visit with your physician.

More chapters in this hub

• Hereditary Cancer Overview

  When hereditary risk is considered and how sequencing works

• Lynch Syndrome

  MMR/MSI, colorectal risk, and family screening

• FAP

  Polyposis, APC, and surgical timing

• CDH1

  Hereditary diffuse gastric cancer risk

• Li-Fraumeni Syndrome

  TP53 and multi-cancer spectrum

• Peutz–Jeghers Syndrome

  Hamartomatous polyps and surveillance

• Genetic Counseling

  Consent, results, and talking with relatives

• Molecular Testing in Cancer

  Organ-specific biomarkers that often open this conversation